The role of DAT-SPECT in movement disorders

被引:228
作者
Kaegi, G. [1 ]
Bhatia, K. P. [1 ]
Tolosa, E. [2 ]
机构
[1] UCL, Natl Hosp Neurol & Neurosurg, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England
[2] Univ Barcelona, Inst Invest Biomed August Pi & Suner, Hosp Clin,Dept Neuol, Parkinsons Dis & Movement Disorders Unit,CIBERNED, Barcelona, Spain
关键词
STRIATAL DOPAMINE TRANSPORTERS; EMISSION COMPUTED-TOMOGRAPHY; MULTIPLE SYSTEM ATROPHY; FP-CIT SPECT; PARKINSONS-DISEASE; ESSENTIAL TREMOR; LEWY BODIES; VASCULAR PARKINSONISM; CLINICAL-DIAGNOSIS; DIFFERENTIAL-DIAGNOSIS;
D O I
10.1136/jnnp.2008.157370
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Dopamine transporter (DAT) imaging is a sensitive method to detect presynaptic dopamine neuronal dysfunction, which is a hallmark of neurodegenerative parkinsonism. DAT imaging can therefore assist the differentiation between conditions with and without presynaptic dopaminergic deficit. Diagnosis of Parkinson disease or tremor disorders can be achieved with high degrees of accuracy in cases with full expression of classical clinical features; however, diagnosis can be difficult, since there is a substantial clinical overlap especially in monosymptomatic tremor (dystonic tremor, essential tremor, Parkinson tremor). The use of DATSPECT can prove or excludes with high sensitivity nigrostriatal dysfunction in those cases and facilitates early and accurate diagnosis. Furthermore, a normal DATSPECT is helpful in supporting a diagnosis of druginduced-, psychogenic-and vascular parkinsonism by excluding underlying true nigrostriatal dysfunction. This review addresses the value of DAT-SPECT and its impact on diagnostic accuracy in movement disorders presenting with tremor and/or parkinsonism.
引用
收藏
页码:5 / 12
页数:8
相关论文
共 83 条
[1]  
Abi-Dargham A, 1996, J NUCL MED, V37, P1129
[2]   PET in LRRK2 mutations: comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation [J].
Adams, JR ;
van Netten, H ;
Schulzer, M ;
Mak, E ;
Mckenzie, J ;
Strongosky, A ;
Sossi, V ;
Ruth, TJ ;
Lee, CS ;
Farrer, M ;
Gasser, T ;
Uitti, RJ ;
Calne, DB ;
Wszolek, ZK ;
Stoessl, AJ .
BRAIN, 2005, 128 :2777-2785
[3]   123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy [J].
Antonini, A ;
Benti, R ;
De Notaris, R ;
Tesei, S ;
Zecchinelli, A ;
Sacilotto, G ;
Meucci, N ;
Canesi, M ;
Mariani, C ;
Pezzoli, G ;
Gerundini, P .
NEUROLOGICAL SCIENCES, 2003, 24 (03) :149-150
[4]   [123I]β-CIT and SPECT in essential tremor and Parkinson's disease [J].
Asenbaum, S ;
Pirker, W ;
Angelberger, P ;
Bencsits, G ;
Pruckmayer, M ;
Brücke, T .
JOURNAL OF NEURAL TRANSMISSION, 1998, 105 (10-12) :1213-1228
[5]   A STUDY OF HEREDITARY ESSENTIAL TREMOR [J].
BAIN, PG ;
FINDLEY, LJ ;
THOMPSON, PD ;
GRESTY, MA ;
ROTHWELL, JC ;
HARDING, AE ;
MARSDEN, CD .
BRAIN, 1994, 117 :805-824
[6]  
Barthel H, 2003, AM J NEURORADIOL, V24, P234
[7]   Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders:: Part 1.: Baseline and 3-month observations [J].
Benamer, HTS ;
Oertel, WH ;
Patterson, J ;
Hadley, DM ;
Pogarell, O ;
Höffken, H ;
Gerstner, A ;
Grosset, DG .
MOVEMENT DISORDERS, 2003, 18 (09) :977-984
[8]  
Benamer HTS, 2000, MOVEMENT DISORD, V15, P692, DOI 10.1002/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO
[9]  
2-V
[10]  
Benamer HTS, 2000, MOVEMENT DISORD, V15, P503, DOI 10.1002/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO